No Picture
News

FDA Grants Priority Review Designation for Heron Therapeutics’ NDA for HTX-011, a Non-Opioid for Postoperative Pain Management

– FDA Assigned PDUFA Goal Date of April 30, 2019 — FDA Not Currently Planning Advisory Committee Meeting for NDA –

SAN DIEGO, Dec. 31, 2018 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on … […]

No Picture
News

FDA Grants Priority Review Designation for Heron Therapeutics’ NDA for HTX-011, a Non-Opioid for Postoperative Pain Management

– FDA Assigned PDUFA Goal Date of April 30, 2019 — FDA Not Currently Planning Advisory Committee Meeting for NDA –

SAN DIEGO, Dec. 31, 2018 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on … […]

No Picture

**Associate Cell Biologist**

ScienCell Research Laboratories (http://www.sciencellonline.com) is a biotechnology company whose mission is the research and development of cell and cell-related products for experimental and therapeutic use. Due to the rapid expending of our busine … […]